DANCR and cholangiocarcinoma: In summary, our study showed that upregulated DANCR could promote CCA progress through transcriptional inactivation of the target tumor suppressor gene FBP1 epigenetically, which revealed that DANCR could provide a theoretical basis for clinical diagnosis and treatment of CCA.